As GLP-1 use keeps climbing, a new worry is getting attention: what the drugs' popularity may be doing to how people see their bodies.
Recap by typeshit. Post by Facebook on Facebook.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
In the 274-person TOGETHER-PsO trial, the combo changed 482 blood proteins versus 140 with Taltz alone, which Lilly says hints at a link between psoriasis and obesity.
Amgen shares are up about 24% this year on interest in its obesity candidate MariTide. One bearish take flags manufacturing scale and a crowded GLP-1 market.
Loading…